Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation
US7531162B2 · kind B2 · utility
11Cited by
102References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 2006 |
| Grant date | May 12, 2009 |
| Priority date | — |
| Expiry date | Jun 11, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent, composition and method for the treatment, prophylaxis and/or diagnosis of proliferative disorders, which is highly and efficiently absorbed at the site of abnormal cellular proliferation is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.